Talaris Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.55
|
0.00
|
0.55
|
100.00%
|
|
2022-12-31
|
-0.51
|
0.00
|
0.51
|
100.00%
|
|
2022-09-30
|
-0.46
|
-0.46
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.46
|
-0.44
|
0.02
|
4.35%
|
|
2022-03-31
|
-0.35
|
-0.45
|
-0.10
|
-28.57%
|
|
2021-12-31
|
-0.35
|
-0.35
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.30
|
-0.32
|
-0.02
|
-6.67%
|
|
2021-06-30
|
-0.26
|
-0.41
|
-0.15
|
-57.69%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.35
|
|
2021-12-31
|
-2.38
|
|
2020-12-31
|
-1.30
|
|
2019-12-31
|
-0.76
|